| A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors (NCT05082610) | Hummingbird Bioscience | 2022-02-28 |
| A PHASE IB STUDY OF IMMUNOTHERAPY WITH EX VIVO PRE-ACTIVATED AND EXPANDED CB-NK CELLS IN COMBINATION WITH CETUXIMAB, IN COLORECTAL CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE (MRD) (NCT05040568) | M.D. Anderson Cancer Center | 2022-02-28 |
| A Study of STP707 Administered by IV in Healthy Subjects (NCT05309915) | Sirnaomics | 2022-02-28 |
| Dengue 4 Human Infection Model (Dengue CVD 11000; DHIM-4) (NCT05268302) | University of Maryland, Baltimore | 2022-02-28 |
| Study to Compare Relative Bioavailability of 3 Indacaterol/Glycopyrronium Test Products and Reference Product (NCT05288075) | Orion Corporation, Orion Pharma | 2022-02-28 |
| A Clinical Study to Evaluate the Safety, Pharmacokinetic Profile and Efficacy of CU-20401 (NCT05195541) | Cutia Therapeutics（Wuxi）Co.,Ltd | 2022-02-27 |
| A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers and Participants With ALS (NCT05279755) | ProJenX | 2022-02-26 |
| Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product (NCT05282940) | Laboratorios Andromaco S.A. | 2022-02-26 |
| A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1) (NCT05222802) | Katmai Pharmaceuticals Inc. | 2022-02-25 |
| Study of Pembrolizumab and M032 (NSC 733972) (NCT05084430) | University of Alabama at Birmingham | 2022-02-25 |
| A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects (NCT05238701) | Luye Pharma Group Ltd. | 2022-02-25 |
| A Study to Evaluate ALN-XDH in Healthy Subjects and Patients With Gout (NCT05256810) | Alnylam Pharmaceuticals | 2022-02-25 |
| A Study of ES104 in Patients With Metastatic Colorectal Cancer (NCT05167448) | Elpiscience (Suzhou) Biopharma, Ltd. | 2022-02-25 |
| Chinese Multiple Dose Escalation (MDE) High Dose Study (NCT05437848) | AstraZeneca | 2022-02-25 |
| A Study of ICP-033 in Patients With Advanced Solid Tumors (NCT05367232) | Beijing InnoCare Pharma Tech Co., Ltd. | 2022-02-25 |
| Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML (NCT05024552) | H. Lee Moffitt Cancer Center and Research Institute | 2022-02-25 |
| Study of Safety, Tolerability and Efficacy of PBKR03 in Pediatric Subjects With Early Infantile Krabbe Disease (NCT04771416) | Gemma Biotherapeutics | 2022-02-24 |
| A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects (NCT05316428) | Vigonvita Life Sciences | 2022-02-24 |
| A Formulation Bridging and Food Effect Study of PBI-200 in Healthy Volunteers (NCT05690932) | Pyramid Biosciences | 2022-02-24 |
| 3D011-08 Monotherapy in Subjects With Advanced Solid Tumors (NCT05099536) | 3D Medicines (Beijing) Co., Ltd. | 2022-02-24 |
| A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of DGX-001 (NCT05121831) | Digestome Therapeutics | 2022-02-24 |
| PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors (NCT05233436) | Pfizer | 2022-02-24 |
| A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling (NCT04773782) | Blueprint Medicines Corporation | 2022-02-24 |
| A Phase 1 Study of the Absorption, Metabolism, and Excretion of [14C] PBI-200 (NCT05238337) | Pyramid Biosciences | 2022-02-24 |
| Safety, Reactogenicity and Immunogenicity of a Novel MVA-SARS-2-ST Vaccine Candidate (NCT05226390) | Hannover Medical School | 2022-02-24 |
| A Phase Ib/ Ⅱ Clinical Study of MIL62 in Primary Membranous Nephropathy (NCT05398653) | Beijing Mabworks Biotech Co., Ltd. | 2022-02-24 |
| A Study of Intratumoral Administration of Oncolytic Virus Injection (RT-01) in Patients With Advanced Solid Tumors (NCT05205408) | The First Affiliated Hospital of Bengbu Medical University | 2022-02-24 |
| A Study of SHR-A1909 in Subjects With Advanced Malignant Tumors (NCT05162469) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2022-02-23 |
| A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) (NCT05121948) | HiberCell, Inc. | 2022-02-23 |
| Safety, Tolerability,PK/PD, Food Effect of Single and Multiple Ascending Doses of HSK31858 in Healthy Volunteers (NCT05663593) | Haisco Pharmaceutical Group Co., Ltd. | 2022-02-23 |
| Autologous Bone Marrow Mesenchymal Stem Cells (BMSCs) Transplantation in the Treatment of Ischemic Stroke (NCT05850208) | Zhujiang Hospital | 2022-02-23 |
| Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake (NCT04799301) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2022-02-23 |
| A Study of JNJ-64281802 in Healthy Adult Participants (NCT05201937) | Janssen Research & Development, LLC | 2022-02-23 |
| Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal Cream (NCT05220293) | Oticara Australia PTY LTD | 2022-02-23 |
| A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of VH3810109 (Also Known as GSK3810109), Administered Either Subcutaneously (SC) With rHuPH20 or Intravenously (IV), in Healthy Adult Participants (NCT05291520) | ViiV Healthcare | 2022-02-23 |
| A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3) (NCT05192356) | Chong Kun Dang Pharmaceutical | 2022-02-23 |
| Study of AT-527 in Healthy Subjects Under Fasting Conditions or With a Meal (NCT05256732) | Atea Pharmaceuticals, Inc. | 2022-02-22 |
| A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR) (NCT06281236) | Sparrow Pharmaceuticals | 2022-02-22 |
| To Evaluate the Pharmacokinetics and the Safety of ID14009 Compared to Coadministration of ID1805 With ID1803 in Healthy Adult Volunteers (NCT05259020) | IlDong Pharmaceutical Co Ltd | 2022-02-22 |
| Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness (NCT05303376) | Immune Biosolutions Inc | 2022-02-22 |
| Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia (NCT05302271) | Weill Medical College of Cornell University | 2022-02-22 |
| Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease (CMT) Type 1A (NCT05333406) | ENCell | 2022-02-22 |
| Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis (NCT05197842) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2022-02-22 |
| Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults (NCT05266456) | Vaxcyte, Inc. | 2022-02-22 |
| Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]PF-07321332 in Healthy Male Participants. (NCT05178654) | Pfizer | 2022-02-22 |
| Ascending Single-Dose and Multiple-Dose Study to Evaluate HSK31679 in Healthy Subjects and Subjects With Elevated LDL-C (NCT05531097) | Haisco Pharmaceutical Group Co., Ltd. | 2022-02-22 |
| Multiple N-of-1 Trials of (Intermittent) Hypoxia Therapy in Parkinson's Disease (NCT05214287) | Radboud University Medical Center | 2022-02-22 |
| A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients (NCT05198817) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2022-02-22 |
| Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma (NCT05002816) | Yale University | 2022-02-21 |
| Extended Cold Stored Apheresis Platelets in Cardiac Surgery Patients (NCT05220787) | Moritz Stolla, MD | 2022-02-21 |
| A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma (NCT05155189) | Zhejiang University | 2022-02-21 |
| A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Itraconazole Capsules (ICZ) (NCT07001501) | Henan Genuine Biotech Co., Ltd. | 2022-02-21 |
| Sustained Acoustic Medicine Ultrasound Diathermy Clinical Performance (NCT05259995) | ZetrOZ, Inc. | 2022-02-21 |
| Effects of Ghrelin Administration on Dopamine and Effort (NCT05318924) | University Hospital Tuebingen | 2022-02-21 |
| Healthy Minds Program App Dosage (NCT05229406) | University of Wisconsin, Madison | 2022-02-21 |
| Study Evaluating PK of PTH Administered Orally Via RaniPill™ Capsule (NCT05164614) | RANI Therapeutics | 2022-02-21 |
| A Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy Subjects (NCT05154240) | InSilico Medicine Hong Kong Limited | 2022-02-21 |
| Intrathecal Pemetrexed for Leptomeningeal Metastasis (NCT05289908) | The First Hospital of Jilin University | 2022-02-21 |
| A Study to Assess YH002 in Combination with YH001 in Subjects with Advanced Solid Tumors (NCT05169697) | Eucure (Beijing) Biopharma Co., Ltd | 2022-02-21 |
| A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Rilpivirine Tablets (RPV) (NCT07001488) | Henan Genuine Biotech Co., Ltd. | 2022-02-21 |
| Effects of Rifampicin and Probenecid On The Pharmacokinetic Profile Of Rongliflozin In Healthy Subjects (NCT05497674) | Sunshine Lake Pharma Co., Ltd. | 2022-02-21 |
| A Study of Epetraborole Tablets in Subjects With Degrees of Renal Function (NCT05283746) | AN2 Therapeutics, Inc | 2022-02-21 |
| Photobiomodulation on the Salivary Glands of Patients With Xerostomia Induced by the Use of Benzodiazepines (NCT05443022) | University of Nove de Julho | 2022-02-20 |
| Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula (NCT05116072) | University Hospital, Lille | 2022-02-20 |
| GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results (NCT05183243) | Suzhou Genhouse Bio Co., Ltd. | 2022-02-20 |
| PI3Kδ Inhibitor Parsaclisib Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-cell Lymphoma (NCT05083208) | Henan Cancer Hospital | 2022-02-20 |
| Comparative Study Between Only Vaginal Misoprostol and Vaginal Misoprostol and Estradiol Cream (NCT05306405) | Ain Shams University | 2022-02-20 |
| Bioequivalence of Xaroban 20mg (Rivaroxaban) Tablet and Xarelto 20mg (Rivaroxaban) Tablet Under Fed Conditions (NCT04689919) | University of Karachi | 2022-02-19 |
| Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant (NCT05027906) | Eledon Pharmaceuticals | 2022-02-18 |
| Safety and Effects of Using Prime-boost HIVIS DNA and MVA-CMDR Vaccine Regimens With or Without Toll-like Receptor 4 Agonist on HIV Reservoirs in Perinatally HIV Infected Children and Youth (NCT04301154) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2022-02-18 |
| A Study in Healthy People to Test How 2 Different Formulations of BI 695501 Are Taken up by the Body When Given as an Injection (NCT05203289) | Boehringer Ingelheim | 2022-02-18 |
| Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic (NCT05415150) | Baylor College of Medicine | 2022-02-18 |
| A Study to Assess the Pharmacokinetics of AZD4831 When Administered Alone and in Combination With Itraconazole (NCT05236543) | AstraZeneca | 2022-02-18 |
| MSC in Patients With Xerostomia Post XRT in Head and Neck Cancer (NCT04489732) | University of Wisconsin, Madison | 2022-02-18 |
| A Study to Investigate the Effect of Single and Repeated Oral Doses of ACT-539313 on What the Body Does to Flurbiprofen, Omeprazole, Midazolam in Healthy Subjects (NCT05254548) | Idorsia Pharmaceuticals Ltd. | 2022-02-18 |
| A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors (NCT04975204) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-02-18 |
| Phase I Study of TSN084 in Patients With Advanced Malignant Tumors. (NCT05300438) | Tyligand Bioscience (Shanghai) Limited | 2022-02-18 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7443904 in Combination With Glofitamab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NCT05219513) | Hoffmann-La Roche | 2022-02-18 |
| A Study to Assess the Effect of Erythromycin on the Test Medicine (SAR443820) When Given Orally as Tablets to Healthy Adult Male and Female Participants (Part A); and the Effect of Itraconazole on the Test Medicine (SAR443820) When Given Orally as Capsules to Healthy Adult Male Participants (Part B) (NCT05797753) | Sanofi | 2022-02-18 |
| Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD) (NCT04604691) | Seoul National University Hospital | 2022-02-18 |
| Dose Response Relationship of Oxytocin on Irritability in Youths (NCT03863288) | University of Nebraska | 2022-02-18 |
| Trial to Investigate the Effect of Dapagliflozin on Ischemia Reperfusion Induced Endothelial Dysfunction (NCT05217654) | Medical University of Vienna | 2022-02-18 |
| Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer (NCT05017025) | M.D. Anderson Cancer Center | 2022-02-17 |
| A Bioequivalence Trial of Irbesartan Tablets（0.15g） in Healthy Chinese Subjects (NCT05297929) | The Affiliated Hospital of Qingdao University | 2022-02-17 |
| Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole (NCT05237297) | Il-Yang Pharm. Co., Ltd. | 2022-02-17 |
| Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis (NCT05363449) | Therapeutics, Inc. | 2022-02-17 |
| The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment (NCT04931095) | Johns Hopkins University | 2022-02-17 |
| A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG (NCT04270838) | University of Oxford | 2022-02-17 |
| A Study to Evaluate Activity, Safety and Tolerability of ZX-101A in Relapsed/Refractory Hematological Malignancies (NCT05269940) | Nanjing Zenshine Pharmaceuticals | 2022-02-17 |
| A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of Adults (NCT05189717) | Shandong Suncadia Medicine Co., Ltd. | 2022-02-17 |
| Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients in China (NCT05120375) | Bio-Thera Solutions | 2022-02-17 |
| D,L-MEthadone and mFOLFOX6 in Treatment of Advanced Colorectal Cancer (NCT05212012) | AIO-Studien-gGmbH | 2022-02-17 |
| A Study to See How BIIB122 Works in the Human Body, and to Evaluate it's Safety, and Tolerability in Healthy Adult Japanese, Chinese, and Caucasian Participants (NCT05229562) | Biogen | 2022-02-17 |
| The Study of CM326 in Patients With Moderate-to-severe Atopic Dermatitis (NCT05186922) | Keymed Biosciences Co.Ltd | 2022-02-17 |
| Safety, Tolerability, and Pharmacokinetics of BGB-23339 in Healthy Japanese and Caucasian Subjects (NCT05387668) | BeiGene | 2022-02-17 |
| JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation (NCT05194995) | Allist Pharmaceuticals, Inc. | 2022-02-17 |
| Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (NCT05032183) | M.D. Anderson Cancer Center | 2022-02-17 |
| Study Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution After Umbilical Cord Blood (UCB) Transplantation in Adult Patients With Hematologic Malignancies (HTLP-ONCO) (NCT04707300) | Assistance Publique - Hôpitaux de Paris | 2022-02-16 |
| Comparison of Tiotropium Absorption From Tiotropium Easyhaler and Spiriva HandiHaler (NCT05246046) | Orion Corporation, Orion Pharma | 2022-02-16 |
| Study to Evaluate Pharmacokinetic and Safety of Albuvirtide Between Intravenous Drip and Intravenous Injection (NCT05206019) | Frontier Biotechnologies Inc. | 2022-02-16 |